ARTICLE
13 June 2022

The Turkish Medicines And Medical Devices Agency Publishes New Draft Guidelines

EG
ELIG Gürkaynak Attorneys-at-Law

Contributor

ELIG Gürkaynak Attorneys-at-Law is an eminent, independent Turkish law firm based in Istanbul. The firm was founded in 2005. ELIG Gürkaynak is committed to providing its clients with high-quality legal services. We combine a solid knowledge of Turkish law with a business-minded approach to develop legal solutions that meet the ever-changing needs of our clients in their international and domestic operations. Our legal team consists of 90 lawyers. We take pride in being able to assist our clients in all fields of law. Our areas of expertise particularly include competition law, corporate law, M&A, contracts law, white collar irregularities and compliance, data protection and cybersecurity law, litigation and dispute resolution, Internet law, technology, media and telecommunications law, intellectual property law, administrative law, real estate law, anti-dumping law, pharma and healthcare regulatory, employment law, and banking and finance law.
On June 7, 2022, the Turkish Medicines and Medical Devices Agency ("Agency") published the Draft Guidelines on Packaging Information and Legibility of Foods for Special Medical Purposes...
Turkey Food, Drugs, Healthcare, Life Sciences

On June 7, 2022, the Turkish Medicines and Medical Devices Agency ("Agency") published the Draft Guidelines on Packaging Information and Legibility of Foods for Special Medical Purposes ("Legibility Guidelines")1 and the Draft Guidelines on New Health Claim Applications ("Application Guidelines")2.

The Legibility Guidelines is indicated to be based on the Regulation on the Licensing of Foods for Special Medical Purposes, and aims to provide the rules and procedures of services and operations to be carried out regarding packaging information and legibility in food license applications for special medical purposes. It defines foods for special medical purposes as all foods that are specially formulated and obtained by industrial methods to be used under medical supervision in order to regulate patient diets (including infants) who have limited, decreased or impaired capacity to take in, digest, absorb, metabolize and remove nutrients or metabolites from the body and whose dietary management cannot be achieved through a normal diet.

The Legibility Guidelines classifies the common technical documentation format in two main modules, consisting of (i) information on packaging and foods for special medical purposes and (iv) the legibility of the packaging information. In the first section, the Legibility Guidelines provides general information on the replacement and specification of foods for special medical purposes, components, warnings and storage. In the second section the Legibility Guidelines lays out information regarding outer and inner packaging. Accordingly, the packaging information of the product should be in line with the specified articles before notifying the Agency.

The Agency has invited concerned parties to submit their comments for the Legibility Guidelines through the e-mail address tıbbi.beslenme@titck.gov.tr until June 27, 2022.

The Application Guidelines, on the other hand, aims to provide the rules and procedures regarding a new health claim application in accordance with the provisions of the Regulation on the Use of Health Claims which is still in its draft form. It covers natural and legal persons applying for new health claim permits.

Per the Application Guidelines, the application must be conveyed in compliance with the table specified in Annex-1 and submitted to the Agency with the Application Form in Annex-2. In order to fulfill a valid application, the Application Guidelines provides a set of requirements. Accordingly, each application should be made for only one relationship between a single declared effect and a nutrient, other elements, food or food group; to indicate the regulation to which the health claim is related. For scientific data, the applicant must submit a summary of the relevant data, and specify whether it is from an appropriate human study or non-human study. The applicant must disclose the cause and effect relationship between the food and the consumption. It is also required to demonstrate the level of representation of the specific working groups from which the evidence and data is obtained. Finally, the Agency provides information and guidelines to companies and natural persons for a new health claim application and the required information and its legibility for packaging.

The Agency has invited concerned parties to submit their comments for the Application Guidelines through the e-mail address bdud.saglikbeyani@titck.gov.tr until June 24, 2022.

Footnotes

1 https://www.titck.gov.tr/duyuru/ozel-tibbi-amacli-gidalarin-ambalaj-bilgilerine-ve-okunabilirliklerine-iliskin-kilavuz-taslagi-07062022160747 (last access: June 13, 2022)

2 https://www.titck.gov.tr/duyuru/yeni-saglik-beyani-basvuru-kilavuz-taslagi-07062022160232 (last access: June 13, 2022)

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More